ADAM17 mutations were not observed in Adrenocortical Carcinoma, Thyroid Carcinoma, Acute Myeloid Leukemia, Cholangiocarcinoma, and Uveal Melanoma. This evidence concerns the gene ADAM17 and acute myeloid leukemia.